Oxford biotech spin-out raises £1.55 million
Crysalin, a spin-out from the University of Oxford's biochemistry department, has secured equity finance of £1.55 million.
News
Crysalin, a spin-out from the University of Oxford's biochemistry department, has secured equity finance of £1.55 million.
News
News
News